What is Weed Inc?
, together with its subsidiaries, focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments in the United States and Australia.
BUDZ · Verdict
Limited reward · high risk
BUDZ has limited near-term tailwinds — cash flow and profitability weigh on the model output.
Based on 88% data coverage
BUDZ · Verdict
Weak vs peers
-2978% return on equity
Current ratio 0.04
Earnings -3.5% CAGR
Below average
Model-based scoring. For information only — not financial advice.
, together with its subsidiaries, focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments in the United States and Australia. The company was formerly known as United Mines, Inc. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 5.93M.
The scoring profile indicates weak reward characteristics across most factors, including momentum and size. Risk indicators are high — this profile reflects meaningful downside exposure.
For informational purposes only. Not financial advice.